Madrigal Pharmaceuticals
MDGL
#2088
Rank
A$13.27 B
Marketcap
A$571.68
Share price
-4.45%
Change (1 day)
-33.22%
Change (1 year)

Earnings for Madrigal Pharmaceuticals (MDGL)

Earnings in 2026 (TTM): -A$0.19 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings are A$1.42 Billion. In 2025 the company made an earning of -A$0.41 Billion, an increase over its 2024 earnings that were of -A$0.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Madrigal Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.19 Billion-54.86%
2025 -A$0.41 Billion-41.05%
2024 -A$0.69 Billion25.02%
2023 -A$0.55 Billion23.86%
2022 -A$0.44 Billion20.24%
2021 -A$0.37 Billion17.25%
2020 -A$0.32 Billion117.61%
2019 -A$0.15 Billion189.45%
2018 -A$49.48 Million3.85%
2017 -A$47.65 Million25.71%
2016 -A$37.91 Million-50.81%
2015 -A$77.06 Million-39.14%
2014 -A$0.13 Billion-4.12%
2013 -A$0.14 Billion
2011 -A$68.52 Million23.13%
2010 -A$55.65 Million-145.81%
2009 A$0.12 B-185.95%
2008 -A$0.15 Billion41.52%
2007 -A$99.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion 29.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$27.38 Million-85.28%๐Ÿ‡บ๐Ÿ‡ธ USA